Mankind Pharma - Superior Execution in Consumer Wellness/Exports Drives Beat on 2Q Estimates
Mankind Pharma (MANKIND) delivered better-than-expected 2QFY25 performance, fueled by a strong revival in growth of the consumer business and...
249 Views
Mankind Pharma - Improvising the Base; Adding New Avenues for Growth
Following our Initiating Coverage on Mankind Pharma (MANKIND), we have highlighted certain key aspects from the recently released annual report.
389 Views
Mankind Pharma: Bharat Serum Acquisition to Be EPS Accretive from FY28
Mankind Pharma (Mankind) has entered into a definitive agreement to acquire a 100% stake in Bharat Serum and Vaccines (BSV) from Advent...
389 Views
Mankind Pharma - Disruptor with a Dose of Care
In a span of 30 years, Mankind Pharma (MANKIND) has built a robust domestic formulation (DF) franchise and become the fourth largest player by...
236 Views
Mankind Pharma (4QFY24): Steady Q4, chronic-focused growth strategy intact. Maintain ADD
India growth was largely led by 15% YoY growth in the chronic segment (outperformance in CVS, anti-diabetics, and CNS) and recovery in gynaecology
495 Views